|
Surgeons at Johns Hopkins
report that by using a blood filtering technique called plasmapheresis,
they have been 93 percent successful in transplanting kidneys
from donors to recipients with incompatible blood types or tissue
proteins.
This would appear to have the potential of significantly expanding
the pool of living donors for kidney patients awaiting transplants,
who until now have needed to find a donor from a compatible blood
group and with a so-called "negative crossmatch."
"With
this innovation, I can tell any patient who has a live donor and
is medically eligible that they can be transplanted with a high
likelihood of success," said Dr. Robert A. Montgomery, assistant
professor of surgery.
Montgomery
said the
technique involves giving patients awaiting a kidney transplant
plasmapheresis treatments every other day
starting a week to 10 days before surgery, and three additional
treatments the week after.
During plasmapheresis,
blood is removed from the patient and a cell separator spins it
at high speed, separating the blood cells from the fluid, or plasma.
The blood cells are then returned to the person undergoing treatment
with other fluids, while the plasma, which contains the antibodies,
is discarded.
Doctors also
give patients intravenously a medication designed to prevent the
antibodies from returning and to make patients less likely to
get an infection.
Montgomery
said that since 1998, they have used this technique on 29 patients
-- five with incompatible blood types with their donors, and 24
with incompatible tissue proteins.
Today, an
average of 17 months after surgery, 27 of the transplanted kidneys
are functioning well, with normal levels of creatinine, a simple
measure of kidney function, he reported.
Other
sources: Johns Hopkins
|